Prolonged Prophylaxis after Joint Replacement: Another Step Sideways?

This publication has 10 references indexed in Scilit:

• Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement
  Annals of Internal Medicine, 2000
• A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
  New England Journal of Medicine, 1999
• Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease
  JAMA, 1999
• Efficacy and Safety of Prolonged Thromboprophylaxis with a Low Molecular Weight Heparin (Dalteparin) after Total Hip Arthroplasty— The Danish Prolonged Prophylaxis (DaPP) Study
  Thrombosis Research, 1998
• Prolonged Thromboprophylaxis Following Hip Replacement Surgery – Results of a Double-blind, Prospective, Randomised, Placebo-controlled Study with Dalteparin (Fragmin®)
  Thrombosis and Haemostasis, 1997
• Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement
  New England Journal of Medicine, 1996
• Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
  The Lancet, 1996
• RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group.
  Journal of Bone and Joint Surgery, 1994
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation
  New England Journal of Medicine, 1993